AstraZeneca Pharma India Limited

6,772.95

INR
-355.70(-4.99%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹18464.15 Cr
Enterprise Value
₹17849.02 Cr
P/E Ratio (TTM)
192.27
Forward P/E
NA
PEG Ratio
NA
Price to Sales (TTM)
13.31

Financial Metrics

Gross Margin
40.53%
Operating Margin
8.81%
Return on Equity
22.69%
Revenue (TTM)
₹1387.58 Cr+31.2%
EBITDA
₹191.53 Cr
EPS (TTM)
₹38.170

Balance Sheet

Total Cash
₹505.57 Cr
Total Debt
₹4.59 Cr
Debt to Equity
0.65%

Stock Information

52 Week Range
₹4510 - ₹8139
Beta
0.30
Shares Outstanding
₹2.50 Cr

Dividends & Splits

Forward Dividend Yield
1.26%
Trailing Dividend Yield
0.00%
Payout Ratio
104.33%

AstraZeneca Pharma India Limited

6,772.95

INR
-355.70(-4.99%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹18464.15 Cr
Enterprise Value
₹17849.02 Cr
P/E Ratio (TTM)
192.27
Forward P/E
NA
PEG Ratio
NA
Price to Sales (TTM)
13.31

Financial Metrics

Gross Margin
40.53%
Operating Margin
8.81%
Return on Equity
22.69%
Revenue (TTM)
₹1387.58 Cr+31.2%
EBITDA
₹191.53 Cr
EPS (TTM)
₹38.170

Balance Sheet

Total Cash
₹505.57 Cr
Total Debt
₹4.59 Cr
Debt to Equity
0.65%

Stock Information

52 Week Range
₹4510 - ₹8139
Beta
0.30
Shares Outstanding
₹2.50 Cr

Dividends & Splits

Forward Dividend Yield
1.26%
Trailing Dividend Yield
0.00%
Payout Ratio
104.33%